By boosting mitochondrial resilience against oxidative stress, mitochondria-targeted antioxidant strategies offer a promising option for therapeutic intervention in IDD
Metabolism Based on an oral 14C-orlistat mass balance study in obese patients, two metabolites, M1 ((the hydrolyzed -lactone ring product of orlistat) and M3 (sequential metabolite after M1's cleavage of the N-formyl leucine side-chain), accounted for approximately 42% of total radioactivity in plasma
Key Benefits: Helps support visible hair density and fullness
This is partly genetic
It is important to note that whilst Ozempic is licensed for type 2 diabetes in the UK, a higher-dose formulation (Wegovy, 2.4 mg weekly) is specifically licensed for weight management in adults with obesity or overweight with weight-related comorbidities, within specialist weight management services and according to NICE criteria (TA875)
Lucena MI, Andrade RJ, de la Cruz JP, Rodriguez-Mendizabal M, Blanco E, Snchez de la Cuesta F